{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T02:08:36Z","timestamp":1772762916284,"version":"3.50.1"},"reference-count":15,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1136\/archdischild-2016-311020","type":"journal-article","created":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T00:50:24Z","timestamp":1498092624000},"page":"899-902","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":18,"title":["Emergency department attendance following 4-component meningococcal B vaccination in infants"],"prefix":"10.1136","volume":"102","author":[{"given":"Sarah","family":"Kapur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Bourke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie-Ann","family":"Maney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Moriarty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2017,6,21]]},"reference":[{"key":"key-10.1136\/archdischild-2016-311020-1","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1016\/j.vaccine.2012.03.011","article-title":"Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccines","volume":"30","author":"Ladhani","year":"2012","journal-title":"Vaccine"},{"key":"key-10.1136\/archdischild-2016-311020-2","unstructured":"Public Health Agency. Meningococcal Disease. http:\/\/www.publichealth.hscni.net\/sites\/default\/files\/directorates\/files\/CalYear-cases-serogroup.pdf (accessed Feb 2016)."},{"key":"key-10.1136\/archdischild-2016-311020-3","unstructured":"JCVI position statement on use of Bexsero\u00ae meningococcal B vaccine in the UK March 2014. https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/294245\/JCVI_Statement_on_MenB.pdf (accessed Jan 2015)."},{"key":"key-10.1136\/archdischild-2016-311020-4","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1016\/j.vaccine.2013.08.006","article-title":"Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage","volume":"31","author":"Frosi","year":"2013","journal-title":"Vaccine"},{"key":"key-10.1136\/archdischild-2016-311020-5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3201\/eid2202.150369","article-title":"Effectiveness of meningococcal B vaccine against endemic hypervirulent Neisseria meningitidis W strain, England","volume":"22","author":"Ladhani","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"key-10.1136\/archdischild-2016-311020-6","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(12)61961-8","article-title":"Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials","volume":"381","author":"Vesikari","year":"2013","journal-title":"Lancet"},{"key":"key-10.1136\/archdischild-2016-311020-7","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.4161\/hv.28666","article-title":"A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine (I): effects of prophylactic paracetamol on immunogenicity and reactogenicity of routine infant vaccines and 4CMenB","volume":"10","author":"Prymula","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"key-10.1136\/archdischild-2016-311020-8","unstructured":"Fever in under 5s: assessment and initial management. NICE guidelines (CG160). www.nice.org.uk\/guidance\/cg160 (accessed Mar 2)."},{"key":"key-10.1136\/archdischild-2016-311020-9","unstructured":"Vaccination Coverage Statistics for Children in Northern Ireland: completed primary immunisations by 12 months. http:\/\/www.publichealthagency.org\/sites\/default\/files\/directorates\/files\/12 months of age_14.pdf (accessed Jan 2016)."},{"key":"key-10.1136\/archdischild-2016-311020-10","volume-title":"Initial dose of a multicomponent serogroup b meningococcal vaccine in the Saguenay-Lac-Saint-Jean Region, Qu\u00e9bec, Canada: an interim safety surveillance report","author":"De Serres","year":"2014"},{"key":"key-10.1136\/archdischild-2016-311020-11","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/INF.0000000000000225","article-title":"The changing epidemiology of serious bacterial infections in young infants","volume":"33","author":"Greenhow","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.1136\/archdischild-2016-311020-12","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/archdischild-2013-305565","article-title":"Very low rates of culture-confirmed invasive bacterial infections in a prospective 3-year population-based surveillance in Southwest London","volume":"99","author":"Le Doare","year":"2014","journal-title":"Arch Dis Child"},{"key":"key-10.1136\/archdischild-2016-311020-13","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1001\/archpedi.1924.04120240054006","article-title":"Leukocytosis in vaccination","volume":"28","author":"Kato","year":"1924","journal-title":"Arch Pediatr Adolesc Med"},{"key":"key-10.1136\/archdischild-2016-311020-14","first-page":"289","article-title":"Pathophysiology of reactions associated with pertussis vaccine","volume":"73","author":"Blumberg","year":"1991","journal-title":"Dev Biol Stand"},{"key":"key-10.1136\/archdischild-2016-311020-15","unstructured":"De Serres G , Gari\u00e9py MC , Billard MN , et al . R\u00e9sultats De La surveillance de la s\u00e9curit\u00e9 des premi\u00e8re et deuxi\u00e8me doses Du vaccin contre le m\u00e9ningocoque de s\u00e9rogroupe B administr\u00e9 au Saguenay-Lac-Saint-Jean. http:\/\/www.inspq.qc.ca\/pdf\/publications\/1975 Securite Vaccin Meningocoque B.pdf (accessed Jan 2016)."}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2016-311020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T11:04:20Z","timestamp":1601118260000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2016-311020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,21]]},"references-count":15,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,9,20]]},"published-print":{"date-parts":[[2017,10]]}},"alternative-id":["10.1136\/archdischild-2016-311020"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2016-311020","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,21]]}}}